Managers / Q4 2022 · view latest →
Global IMC LLC
CIK 0001741619 · 215 HIGHWAY 101, SUITE 216, SOLANA BEACH, CA, 92075 · 760-479-5080
Reported Value
$387M
Q4 2022
Positions
175
Filings on Record
30
2019–present window
Filed
Feb 14, 2023
original filing
Summary
Global Imc LLC reported $387M in U.S.-listed holdings across 175 positions for Q4 2022.
Its largest position, VIPS, represents 1.6% of the portfolio.
Compared with Q3 2022, the fund opened 90 new positions and exited 87.
Portfolio Metrics
Turnover
+52.6%
vs prior filed quarter
Top-10 Concentration
+13.6%
share of reported value
Largest Position
+1.6%
Vipshop
New / Exited
90 / 87
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 93.9% · $364M
- Other · 4.6% · $18M
- ADR · 1.6% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VIPSVipshop Holdings Ltd | NEW | +441.4K | 441.4K | +$6M | $6M |
| WFRDWeatherford International PLC | NEW | +93.1K | 93.1K | +$5M | $5M |
| PLXSPlexus Corp | NEW | +35.4K | 35.4K | +$4M | $4M |
| AINAlbany International Corp | NEW | +36.0K | 36.0K | +$4M | $4M |
| SPXCSPX Technologies Inc | NEW | +53.4K | 53.4K | +$4M | $4M |
| CLDXCelldex Therapeutics Inc | NEW | +72.1K | 72.1K | +$3M | $3M |
| BANRBanner Corp | NEW | +48.5K | 48.5K | +$3M | $3M |
| PARRPar Pacific Holdings Inc | NEW | +118.8K | 118.8K | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
175 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | VIPSVipshop Holdings Ltdhistory → | Common Stock | 1.56% | $6M | 441.4K |
| 2 | AGYSAgilysys Inchistory → | Common Stock | 1.51% | $6M | 73.7K |
| 3 | PIImpinj Inchistory → | Common Stock | 1.50% | $6M | 53.3K |
| 4 | XENEXenon Pharmaceuticals Inchistory → | Common Stock | 1.49% | $6M | 146.4K |
| 5 | TMDXTransMedics Group Inchistory → | Common Stock | 1.36% | $5M | 85.0K |
| 6 | Enerplus Corp | Common Stock | 1.27% | $5M | 279.3K |
| 7 | ELFelf Beauty Inchistory → | Common Stock | 1.26% | $5M | 88.5K |
| 8 | DGIIDigi International Inchistory → | Common Stock | 1.24% | $5M | 131.4K |
| 9 | WFRDWeatherford International PLChistory → | Common Stock | 1.22% | $5M | 93.1K |
| 10 | EXTRExtreme Networks Inchistory → | Common Stock | 1.22% | $5M | 257.2K |
| 11 | PRTAProthena Corp PLChistory → | Common Stock | 1.19% | $5M | 76.7K |
| 12 | MGPIMGP Ingredients Inchistory → | Common Stock | 1.18% | $5M | 43.1K |
| 13 | MODModine Manufacturing Cohistory → | Common Stock | 1.16% | $4M | 225.3K |
| 14 | VRDNViridian Therapeutics Inchistory → | Common Stock | 1.15% | $4M | 151.9K |
| 15 | HURNHuron Consulting Group Inchistory → | Common Stock | 1.07% | $4M | 57.2K |
| 16 | UFPTUFP Technologies Inchistory → | Common Stock | 1.05% | $4M | 34.6K |
| 17 | Oaktree Capital Group Holdings LP | Common Stock | 1.05% | $4M | 139.7K |
| 18 | Super Micro Computer Inc | Common Stock | 1.01% | $4M | 47.5K |
| 19 | PLXSPlexus Corp | Common Stock | 0.94% | $4M | 35.4K |
| 20 | AINAlbany International Corp | Common Stock | 0.92% | $4M | 36.0K |
| 21 | PHRPhreesia Inc | Common Stock | 0.91% | $4M | 109.1K |
| 22 | SPXCSPX Technologies Inc | Common Stock | 0.91% | $4M | 53.4K |
| 23 | IVERIC bio Inc | Common Stock | 0.90% | $3M | 162.1K |
| 24 | ACLSAxcelis Technologies Inc | Common Stock | 0.88% | $3M | 42.9K |
| 25 | NOGNorthern Oil and Gas Inc | Common Stock | 0.85% | $3M | 106.3K |
| 26 | ADMAADMA Biologics Inc | Common Stock | 0.84% | $3M | 836.3K |
| 27 | CLDXCelldex Therapeutics Inc | Common Stock | 0.83% | $3M | 72.1K |
| 28 | SANMSanmina Corp | Common Stock | 0.80% | $3M | 53.8K |
| 29 | BANRBanner Corp | Common Stock | 0.79% | $3M | 48.5K |
| 30 | HLITHarmonic Inc | Common Stock | 0.79% | $3M | 232.6K |
| 31 | ACHCAcadia Healthcare Co Inc | Common Stock | 0.77% | $3M | 36.2K |
| 32 | VMDViemed Healthcare Inc | Common Stock | 0.76% | $3M | 387.9K |
| 33 | Euronav NV | Common Stock | 0.73% | $3M | 166.9K |
| 34 | POSTPost Holdings Inc | Common Stock | 0.72% | $3M | 30.8K |
| 35 | PARRPar Pacific Holdings Inc | Common Stock | 0.71% | $3M | 118.8K |
| 36 | CLFDClearfield Inc | Common Stock | 0.71% | $3M | 29.1K |
| 37 | EXLSExlService Holdings Inc | Common Stock | 0.66% | $3M | 15.0K |
| 38 | Prometheus Biosciences Inc | Common Stock | 0.65% | $3M | 22.9K |
| 39 | Frontline Ltd/Bermuda | Common Stock | 0.64% | $2M | 204.0K |
| 40 | WNCWabash National Corp | Common Stock | 0.63% | $2M | 107.7K |
| 41 | Arcellx Inc | Common Stock | 0.63% | $2M | 78.4K |
| 42 | Hostess Brands Inc | Common Stock | 0.62% | $2M | 107.4K |
| 43 | IRDMIridium Communications Inc | Common Stock | 0.62% | $2M | 46.6K |
| 44 | CALXCalix Inc | Common Stock | 0.62% | $2M | 34.9K |
| 45 | STRLSterling Infrastructure Inc | Common Stock | 0.62% | $2M | 72.8K |
| 46 | KLXEKLX Energy Services Holdings Inc | Common Stock | 0.61% | $2M | 137.5K |
| 47 | ATENA10 Networks Inc | Common Stock | 0.61% | $2M | 142.1K |
| 48 | TDWTidewater Inc | Common Stock | 0.59% | $2M | 62.4K |
| 49 | CROXCrocs Inc | Common Stock | 0.59% | $2M | 21.1K |
| 50 | WSCWillScot Mobile Mini Holdings Corp | Common Stock | 0.59% | $2M | 50.6K |
| 51 | FIXComfort Systems USA Inc | Common Stock | 0.58% | $2M | 19.6K |
| 52 | BBSIBarrett Business Services Inc | Common Stock | 0.58% | $2M | 23.9K |
| 53 | GFFGriffon Corp | Common Stock | 0.57% | $2M | 62.1K |
| 54 | Provention Bio Inc | Common Stock | 0.57% | $2M | 209.9K |
| 55 | AITApplied Industrial Technologies Inc | Common Stock | 0.57% | $2M | 17.6K |
| 56 | CELHCelsius Holdings Inc | Common Stock | 0.57% | $2M | 21.0K |
| 57 | CBZCBIZ Inc | Common Stock | 0.56% | $2M | 46.5K |
| 58 | HLXHelix Energy Solutions Group Inc | Common Stock | 0.56% | $2M | 293.4K |
| 59 | EMEEMCOR Group Inc | Common Stock | 0.56% | $2M | 14.5K |
| 60 | FSLRFirst Solar Inc | Common Stock | 0.54% | $2M | 14.1K |
| 61 | Blucora Inc | Common Stock | 0.54% | $2M | 82.1K |
| 62 | HALOHalozyme Therapeutics Inc | Common Stock | 0.54% | $2M | 36.8K |
| 63 | MUSAMurphy USA Inc | Common Stock | 0.54% | $2M | 7.4K |
| 64 | CN2Catalyst Pharmaceuticals Inc | Common Stock | 0.54% | $2M | 111.5K |
| 65 | DXLGDestination XL Group Inc | Common Stock | 0.53% | $2M | 305.4K |
| 66 | RGAReinsurance Group of America Inc | Common Stock | 0.53% | $2M | 14.5K |
| 67 | ASOAcademy Sports & Outdoors Inc | Common Stock | 0.53% | $2M | 38.9K |
| 68 | UTHRUnited Therapeutics Corp | Common Stock | 0.53% | $2M | 7.3K |
| 69 | Model N Inc | Common Stock | 0.52% | $2M | 50.0K |
| 70 | NBIXNeurocrine Biosciences Inc | Common Stock | 0.52% | $2M | 16.8K |
| 71 | CWCurtiss-Wright Corp | Common Stock | 0.52% | $2M | 11.9K |
| 72 | ACMAECOM | Common Stock | 0.51% | $2M | 23.5K |
| 73 | VKTXViking Therapeutics Inc | Common Stock | 0.51% | $2M | 211.2K |
| 74 | BDCBelden Inc | Common Stock | 0.51% | $2M | 27.4K |
| 75 | DAYCeridian HCM Holding Inc | Common Stock | 0.51% | $2M | 30.7K |
| 76 | ChampionX Corp | Common Stock | 0.51% | $2M | 67.9K |
| 77 | PCVXVaxcyte Inc | Common Stock | 0.51% | $2M | 41.0K |
| 78 | Cymabay Therapeutics Inc | Common Stock | 0.50% | $2M | 311.8K |
| 79 | Str Sub Inc | Common Stock | 0.50% | $2M | 67.7K |
| 80 | VMIValmont Industries Inc | Common Stock | 0.50% | $2M | 5.9K |
| 81 | WRBW R Berkley Corp | Common Stock | 0.50% | $2M | 26.7K |
| 82 | BMIBadger Meter Inc | Common Stock | 0.49% | $2M | 17.5K |
| 83 | SNEXStoneX Group Inc | Common Stock | 0.49% | $2M | 20.0K |
| 84 | CECOCECO Environmental Corp | Common Stock | 0.49% | $2M | 162.8K |
| 85 | UBSIUnited Bankshares Inc/WV | Common Stock | 0.49% | $2M | 46.5K |
| 86 | DNOWNOW Inc | Common Stock | 0.49% | $2M | 147.9K |
| 87 | RMBSRambus Inc | Common Stock | 0.48% | $2M | 52.2K |
| 88 | DINOHF Sinclair Corp | Common Stock | 0.48% | $2M | 35.9K |
| 89 | Silk Road Medical Inc | Common Stock | 0.48% | $2M | 35.1K |
| 90 | MGRCMcGrath RentCorp | Common Stock | 0.48% | $2M | 18.8K |
| 91 | SRPTSarepta Therapeutics Inc | Common Stock | 0.48% | $2M | 14.3K |
| 92 | RLIRLI Corp | Common Stock | 0.48% | $2M | 14.1K |
| 93 | BBWBuild-A-Bear Workshop Inc | Common Stock | 0.48% | $2M | 77.4K |
| 94 | INSPInspire Medical Systems Inc | Common Stock | 0.47% | $2M | 7.3K |
| 95 | AKROAkero Therapeutics Inc | Common Stock | 0.47% | $2M | 33.5K |
| 96 | SUPNSupernus Pharmaceuticals Inc | Common Stock | 0.47% | $2M | 51.5K |
| 97 | OIIOceaneering International Inc | Common Stock | 0.47% | $2M | 104.9K |
| 98 | STNGScorpio Tankers Inc | Common Stock | 0.47% | $2M | 34.0K |
| 99 | RYTMRhythm Pharmaceuticals Inc | Common Stock | 0.47% | $2M | 62.6K |
| 100 | NOVNOV Inc | Common Stock | 0.47% | $2M | 87.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $47M | 16 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $23M | 9 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $24M | 11 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $386M | 80 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $367M | 80 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $557M | 121 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $496M | 99 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $445M | 88 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $433M | 89 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $414M | 98 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $370M | 98 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $340M | 81 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $356M | 81 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $387M | 175 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $376M | 172 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $407M | 179 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $542M | 198 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $563M | 194 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $423M | 187 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $361M | 141 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $361M | 139 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $369M | 130 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $273M | 125 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $222M | 118 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $171M | 101 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $250M | 109 | Feb 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $205M | 113 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $235M | 124 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $226M | 124 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $183M | 126 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.